Press releasesKeep up with the latest news from Ikena Oncology.December 19, 2018 Kyn Therapeutics Announces Initiation of Phase 1b/2 Clinical Studies of ARY-007 in Collaboration with MerckMarch 21, 2018 Kyn Therapeutics Appoints Chairman and Scientific Advisory Board MemberDecember 14, 2017 Kyn Therapeutics Announces $49 Million Series A Capital Available to Develop Cancer Therapy Candidates with Novel Approaches to Major Immunometabolism Pathways <<12Access our media kit page to view and download assorted corporate assets.View Media Kit
